XML 30 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series A
Preferred Stock
Leafly Holdings, Inc.
Common Stock
Additional Paid-in Capital
Leafly Holdings, Inc.
Additional Paid-in Capital
Accumulated Deficit
Leafly Holdings, Inc.
Accumulated Deficit
Class 1, Class 2, and Class 3 Common Stock
Leafly Holdings, Inc.
Leafly Holdings, Inc.
Total
Balance at Dec. 31, 2018 $ 2,000   $ 8,370,000   $ (15,846,000)   $ (7,474,000)  
Balance (in Shares) at Dec. 31, 2018 22,000,000              
Conversion of Series A preferred stock into common stock $ (2,000)   (2,000)     $ 4,000  
Conversion of Series A preferred stock into common stock (in Shares) (22,000,000)           41,692,743    
Net income (loss)     (31,936,000)   (31,936,000)  
Stock-based compensation   380,000     380,000  
Exercise of stock options   365,000     $ 1,000 366,000  
Exercise of stock options (in Shares)             6,319,709    
Common stock issued   25,997,000     $ 3,000 26,000,000  
Common stock issued (in Shares)             26,490,876    
Common stock contributed by Privateer   1,000     $ (1,000)  
Common stock contributed by Privateer (in Shares)             (3,863,969)    
Common stock issued in exchange for settlement of Privateer related party payables   6,022,000     $ 1,000 6,023,000  
Common stock issued in exchange for settlement of Privateer related party payables (in Shares)             6,136,381    
Extinguishment of Privateer related party payables   1,455,000     1,455,000  
Balance at Dec. 31, 2019 $ 402 42,588,000 $ 3,693,446 (47,782,000) $ 1,306,153 $ 8,000 (5,186,000) $ 5,000,001
Balance (in Shares) at Dec. 31, 2019 4,018,703         76,775,740    
Balance at Jun. 19, 2019          
Balance (in Shares) at Jun. 19, 2019                
Issuance of common stock to Sponsor   $ 345   24,655       25,000
Issuance of common stock to Sponsor (in Shares)   3,450,000              
Issuance of Representative Shares   $ 12   898       910
Issuance of Representative Shares (in Shares)   120,000              
Sale of 13,001,552 Units, net of underwriting discounts and offering expenses   $ 1,300   126,621,227       126,622,527
Sale of 13,001,552 Units, net of underwriting discounts and offering expenses (in Shares)   13,001,552              
Proceeds received in excess of fair value of Private Warrants     750,559       750,559
Change in value of common stock subject to possible redemption   $ (1,235)   (123,703,913)       (123,705,148)
Change in value of common stock subject to possible redemption (in Shares)   (12,353,237)              
Forfeiture of Founder Shares   $ (20)   20      
Forfeiture of Founder Shares (in Shares)   (199,612)              
Net income (loss)       1,306,153     1,306,153
Balance at Dec. 31, 2019 $ 402 42,588,000 3,693,446 (47,782,000) 1,306,153 $ 8,000 (5,186,000) 5,000,001
Balance (in Shares) at Dec. 31, 2019 4,018,703         76,775,740    
Change in value of common stock subject to possible redemption     (376,321)       (376,321)
Change in value of common stock subject to possible redemption (in Shares)   (5,599)              
Net income (loss)       376,330     376,330
Balance at Mar. 31, 2020   $ 402   3,317,125   1,682,483     5,000,010
Balance (in Shares) at Mar. 31, 2020   4,013,104              
Balance at Dec. 31, 2019 $ 402 42,588,000 3,693,446 (47,782,000) 1,306,153 $ 8,000 (5,186,000) 5,000,001
Balance (in Shares) at Dec. 31, 2019 4,018,703         76,775,740    
Net income (loss)     (8,343,000)   (8,343,000)  
Stock-based compensation   358,000     358,000  
Issuance of Series A convertible preferred stock   3,490,000     3,490,000  
Issuance of Series A convertible preferred stock (in Shares) 3,488,000              
Exercise of stock options   197,000     197,000  
Exercise of stock options (in Shares)           393,000    
Balance at Jun. 30, 2020 $ 403 46,633,000 3,416,084 (56,125,000) 1,583,517 $ 8,000 (9,484,000) 5,000,004
Balance (in Shares) at Jun. 30, 2020 3,488,000 4,023,123         77,169,000    
Balance at Dec. 31, 2019 $ 402 42,588,000 3,693,446 (47,782,000) 1,306,153 $ 8,000 (5,186,000) 5,000,001
Balance (in Shares) at Dec. 31, 2019 4,018,703         76,775,740    
Change in value of common stock subject to possible redemption   $ 22   1,874,067       1,874,089
Change in value of common stock subject to possible redemption (in Shares)   219,541              
Net income (loss) (9,964,000) (1,874,080) (9,964,000) (1,874,080)
Stock-based compensation   1,158,000     1,158,000  
Issuance of Series A convertible preferred stock               30,000  
Exercise of stock options   733,000     $ 733,000  
Exercise of stock options (in Shares)             548,027 548  
Common stock repurchased        
Common stock repurchased (in Shares)           (1,929,164)    
Conversion of promissory notes into Series A preferred stock, net $ 2,000   11,836,000     11,838,000  
Conversion of promissory notes into Series A preferred stock, net (in Shares) 15,214,153              
Series A preferred stock issued, net   3,490,000     3,490,000  
Series A preferred stock issued, net (in Shares) 3,488,339              
Balance at Dec. 31, 2020 $ 2,000 $ 424 59,805,000 5,567,513 (57,746,000) (567,927) $ 8,000 2,069,000 5,000,010
Balance (in Shares) at Dec. 31, 2020 18,702,492 4,238,244         75,394,603    
Balance at Mar. 31, 2020   $ 402   3,317,125   1,682,483     5,000,010
Balance (in Shares) at Mar. 31, 2020   4,013,104              
Change in value of common stock subject to possible redemption   $ 1   98,959       98,960
Change in value of common stock subject to possible redemption (in Shares)   10,019              
Net income (loss)       (98,966)     (98,966)
Balance at Jun. 30, 2020 $ 403 46,633,000 3,416,084 (56,125,000) 1,583,517 $ 8,000 (9,484,000) 5,000,004
Balance (in Shares) at Jun. 30, 2020 3,488,000 4,023,123         77,169,000    
Balance at Dec. 31, 2020 $ 2,000 $ 424 59,805,000 5,567,513 (57,746,000) (567,927) $ 8,000 2,069,000 5,000,010
Balance (in Shares) at Dec. 31, 2020 18,702,492 4,238,244         75,394,603    
Change in value of common stock subject to possible redemption   $ 6   885,995       886,001
Change in value of common stock subject to possible redemption (in Shares)   67,083              
Net income (loss)       (886,006)     (886,006)
Balance at Mar. 31, 2021   $ 430   6,453,508   (1,453,933)     5,000,005
Balance (in Shares) at Mar. 31, 2021   4,305,327              
Balance at Dec. 31, 2020 $ 2,000 $ 424 59,805,000 5,567,513 (57,746,000) (567,927) $ 8,000 2,069,000 5,000,010
Balance (in Shares) at Dec. 31, 2020 18,702,492 4,238,244         75,394,603    
Net income (loss)     (2,426,000)   (2,426,000)  
Stock-based compensation   521,000     521,000  
Exercise of stock options   108,000     $ 108,000  
Exercise of stock options (in Shares)           260,000 260  
Balance at Jun. 30, 2021 $ 2,000 $ 435 60,434,000 6,884,301 (60,172,000) (1,884,733) $ 8,000 $ 272,000 5,000,003
Balance (in Shares) at Jun. 30, 2021 18,702,000 4,339,859         75,655,000    
Balance at Mar. 31, 2021   $ 430   6,453,508   (1,453,933)     5,000,005
Balance (in Shares) at Mar. 31, 2021   4,305,327              
Change in value of common stock subject to possible redemption   $ 5   430,793       430,798
Change in value of common stock subject to possible redemption (in Shares)   34,532              
Net income (loss)       (430,800)     (430,800)
Balance at Jun. 30, 2021 $ 2,000 $ 435 $ 60,434,000 $ 6,884,301 $ (60,172,000) $ (1,884,733) $ 8,000 $ 272,000 $ 5,000,003
Balance (in Shares) at Jun. 30, 2021 18,702,000 4,339,859         75,655,000